摘要
目的 探讨良性前列腺增生采用经尿道前列腺等离子切除术与铥激光剜除术治疗的效果。方法 选取2016年2月至2018年3月收治的良性前列腺增生患者98例,按单盲法分为两组。试验组49例采用经尿道前列腺铥激光剜除术,对照组49例采用经尿道前列腺等离子切除术,比较两组围术期指标、前列腺症状、最大尿流率、并发症。结果 术后6个月,两组国际前列腺症状评分(IPSS)较术前低,最大尿流率(Qmax)较术前高(P<0.05),但组间相比差异无统计学意义(P>0.05);与对照组相比,试验组出血量少,膀胱冲洗时间、住院时间短,并发症发生率低,差异有统计学意义(P<0.05)。结论 相较于经尿道前列腺等离子切除术,铥激光剜除术治疗良性前列腺增生效果确切,具有并发症少、微创等优点,利于患者预后。
Objective To investigate the effects of transurethral plasmakinetic resection and thulium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia(BPH). Methods 98 patients with BPH admitted to hospital from February 2016 to March 2018 were divided into two groups by single blind method.Experimental group(49 cases) underwent transurethral thulium laser enucleation of the prostate,and control group(49 cases) were given plasmakinetic resection of the prostate.And then,perioperative indexes,prostate symptoms,maximal urinary flow rates and complications were compared between the two groups. Results 6 months after surgery,International Prostate Symptom Score(IPSS) in the two groups were lower than those before surgery,and the maximal urinary flow rates(Q max ) were higher than those before surgery( P <0.05),but there was no statistically significant difference between the two groups( P >0.05).Compared with the control group,bleeding volume of the experimental group was less,bladder washing time and hospital stays were shorter,and the incidence of complications was lower,difference was statistically significant( P <0.05). Conclusion Compared with plasmakinetic resection of the prostate,thulium laser enucleation in the treatment of BPH is effective with the advantages of less complications and minimal invasions,which is beneficial to the prognosis of patients.
作者
王文浩
杨登科
焦湘
WANG Wenhao;YANG Dengke;JIAO Xiang(Department of Urinary Surgery,No.990 Hospital of Joint Logistics Support Force of The Chinese People’s Liberation Army,Zhumadian 463000,China)
出处
《右江医学》
2019年第9期694-697,共4页
Chinese Youjiang Medical Journal
关键词
良性前列腺增生
铥激光剜除术
经尿道前列腺等离子切除术
benign prostatic hyperplasia
thulium laser enucleation
transurethral plasmakinetic resection of the prostate